Search global stocks & ETFs...Ctrl K
Learn Mode
Corcept Therapeutics IncCORT
$79.91
-$1.84 (-2.251%)
$80.73
$0.82 (1.027%)
CORT
Stock Profile
07-29
Recommended Metric
Score Card
Explore Scores Tab
3.07
Average
Valuation Score
Key Score
1.00
Very Bad
Management
5.00
Very Good
Growth
4.00
Good
Profitability
5.00
Very Good
Fin. Health
3.00
Average
Dividends
--
--
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$79.91
Baseline
High
$115.50
▲
44.54%
Avg
$74.87
▼
-6.31%
Low
$44.44
▼
-44.39%
Analyst Ratings based on 12 Analysts
Strong Buy
217%
Buy
867%
Hold
217%
Sell
000%
Strong Sell
000%
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company is headquartered in Redwood City, California and currently employs 730 full-time employees. The company went IPO on 2004-04-15. The firm is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.Read More